BIOMAT Database Logo BIOMAT Database Logo

Phase II trial of mitoxantrone in previously untreated patients with colorectal adenocarcinoma: A Southwest Oncology Group Study. 1982

J D Cowan, and D D Von Hoff, and B McDonald, and R W Talley, and J D McCracken, and T Chen

UI MeSH Term Description Entries
D007970 Leukopenia A decrease in the number of LEUKOCYTES in a blood sample below the normal range (LEUKOCYTE COUNT less than 4000). Leukocytopenia,Leukocytopenias,Leukopenias
D008297 Male Males
D008875 Middle Aged An adult aged 45 - 64 years. Middle Age
D008942 Mitoxantrone An anthracenedione-derived antineoplastic agent. Mitozantrone,CL-232325,DHAQ,Mitoxantrone Acetate,Mitoxantrone Hydrochloride,Mitroxone,NSC-279836,NSC-287836,NSC-299195,NSC-301739,NSC-301739D,Novantron,Novantrone,Onkotrone,Pralifan,Ralenova,Acetate, Mitoxantrone,CL 232325,CL232325,Hydrochloride, Mitoxantrone,NSC 279836,NSC 287836,NSC 299195,NSC 301739,NSC 301739D,NSC279836,NSC287836,NSC299195,NSC301739,NSC301739D
D009325 Nausea An unpleasant sensation in the stomach usually accompanied by the urge to vomit. Common causes are early pregnancy, sea and motion sickness, emotional stress, intense pain, food poisoning, and various enteroviruses.
D012004 Rectal Neoplasms Tumors or cancer of the RECTUM. Cancer of Rectum,Rectal Cancer,Rectal Tumors,Cancer of the Rectum,Neoplasms, Rectal,Rectum Cancer,Rectum Neoplasms,Cancer, Rectal,Cancer, Rectum,Neoplasm, Rectal,Neoplasm, Rectum,Rectal Cancers,Rectal Neoplasm,Rectal Tumor,Rectum Cancers,Rectum Neoplasm,Tumor, Rectal
D003110 Colonic Neoplasms Tumors or cancer of the COLON. Cancer of Colon,Colon Adenocarcinoma,Colon Cancer,Cancer of the Colon,Colon Neoplasms,Colonic Cancer,Neoplasms, Colonic,Adenocarcinoma, Colon,Adenocarcinomas, Colon,Cancer, Colon,Cancer, Colonic,Cancers, Colon,Cancers, Colonic,Colon Adenocarcinomas,Colon Cancers,Colon Neoplasm,Colonic Cancers,Colonic Neoplasm,Neoplasm, Colon,Neoplasm, Colonic,Neoplasms, Colon
D004341 Drug Evaluation Any process by which toxicity, metabolism, absorption, elimination, preferred route of administration, safe dosage range, etc., for a drug or group of drugs is determined through clinical assessment in humans or veterinary animals. Evaluation Studies, Drug,Drug Evaluation Studies,Drug Evaluation Study,Drug Evaluations,Evaluation Study, Drug,Evaluation, Drug,Evaluations, Drug,Studies, Drug Evaluation,Study, Drug Evaluation
D004353 Drug Evaluation, Preclinical Preclinical testing of drugs in experimental animals or in vitro for their biological and toxic effects and potential clinical applications. Drug Screening,Evaluation Studies, Drug, Pre-Clinical,Drug Evaluation Studies, Preclinical,Drug Evaluations, Preclinical,Evaluation Studies, Drug, Preclinical,Evaluation, Preclinical Drug,Evaluations, Preclinical Drug,Medicinal Plants Testing, Preclinical,Preclinical Drug Evaluation,Preclinical Drug Evaluations,Drug Screenings,Screening, Drug,Screenings, Drug
D005260 Female Females

Related Publications

J D Cowan, and D D Von Hoff, and B McDonald, and R W Talley, and J D McCracken, and T Chen
Phase II study of fludarabine phosphate in previously untreated patients with colorectal carcinoma: a Southwest Oncology Group Study.
December 1987, Cancer treatment reports,
J D Cowan, and D D Von Hoff, and B McDonald, and R W Talley, and J D McCracken, and T Chen
Phase II evaluation of ftorafur in previously untreated colorectal cancer: a Southwest Oncology Group Study.
July 1979, Cancer,
J D Cowan, and D D Von Hoff, and B McDonald, and R W Talley, and J D McCracken, and T Chen
Phase II study of fludarabine phosphate in previously untreated patients with hepatoma: a Southwest Oncology Group Study.
November 1987, Cancer treatment reports,
J D Cowan, and D D Von Hoff, and B McDonald, and R W Talley, and J D McCracken, and T Chen
Phase II trial of mitoxantrone in multiple myeloma: a Southwest Oncology Group Study.
November 1985, Cancer treatment reports,
J D Cowan, and D D Von Hoff, and B McDonald, and R W Talley, and J D McCracken, and T Chen
Phase II trial of mitoxantrone in advanced sarcomas: a Southwest Oncology Group study.
February 1985, Cancer treatment reports,
J D Cowan, and D D Von Hoff, and B McDonald, and R W Talley, and J D McCracken, and T Chen
Phase II study of trimetrexate in previously untreated patients with hepatocellular carcinoma. Southwest Oncology Group study 8712.
February 1993, Investigational new drugs,
J D Cowan, and D D Von Hoff, and B McDonald, and R W Talley, and J D McCracken, and T Chen
A phase II trial of intravenous vinorelbine in previously untreated patients with extensive small cell lung cancer, a Southwest Oncology Group study.
January 1997, Investigational new drugs,
J D Cowan, and D D Von Hoff, and B McDonald, and R W Talley, and J D McCracken, and T Chen
Phase II clinical trial of mitoxantrone in patients with advanced renal cell carcinoma: a Southwest Oncology Group study.
June 1984, Cancer treatment reports,
J D Cowan, and D D Von Hoff, and B McDonald, and R W Talley, and J D McCracken, and T Chen
Phase II trial of diaziquone in advanced large bowel carcinoma in previously treated and untreated patients: a Southwest Oncology Group Study.
June 1985, Cancer treatment reports,
J D Cowan, and D D Von Hoff, and B McDonald, and R W Talley, and J D McCracken, and T Chen
A phase II trial of recombinant tumor necrosis factor in patients with metastatic colorectal adenocarcinoma: a Southwest Oncology Group study.
December 1990, Journal of biological response modifiers,
Copied contents to your clipboard!